![Krista McKerracher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Krista McKerracher
Directeur/Membre du Conseil chez
NERVGEN PHARMA CORP.
Fortune : 86 685 $ au 30/09/2026
Profil
Krista Lee McKerracher is the founder of FIG Advisory LLC.
Ms. McKerracher currently serves as an Independent Non-Executive Director at NervGen Pharma Corp.
since 2021.
Ms. McKerracher also holds the position of Vice President & Head-Hemoglobinopathy at CRISPR Therapeutics, Inc. Ms. McKerracher completed undergraduate studies at The University of Waterloo and earned an MBA from The Schulich School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NERVGEN PHARMA CORP. 0,04 % | 04/09/2026 | 45 385 ( 0,04 % ) | 86 685 $ | 30/09/2026 |
Postes actifs de Krista McKerracher
| Sociétés | Poste | Début |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur/Membre du Conseil | 01/09/2021 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Corporate Officer/Principal | - |
Anciens postes connus de Krista McKerracher
| Sociétés | Poste | Fin |
|---|---|---|
FIG Advisory LLC | Fondateur | - |
Formation de Krista McKerracher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
FIG Advisory LLC |
